Key Drivers
- Margin strength
- Strong cash flow
- Premium multiples
AIAI Summary
STE is a high-quality healthcare compounder rather than a fast-growth story, and the key investment takeaway is that its premium valuation now depends on preserving margins and free-cash-flow conversion as tariffs and inflation pressure gross and EBIT margins.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin strength
- •Strong cash flow
- •Premium multiples
STE combines solid profitability, strong free cash flow, and healthy liquidity with moderate leverage, but a large intangible asset base and premium valuation multiples limit upside.
Price Behavior
Key Price Behavior Insights:
- •Higher lows
- •Breakout hold
- •Overextended rally
STE has shifted from choppy to constructive over the last month, breaking above $215-$216 and forming higher lows, but the fast rebound leaves it vulnerable to a short-term pause unless it holds $210-$212.
Sharp rebound from the $199.40 low suggests near-term volatility risk
Sentiment & News
Key News Insights:
- •Long-term momentum
- •Growth-screen favor
- •Modest earnings move
Steris is attracting repeated positive growth and momentum screen attention, while its post-earnings share move has remained modest and stable.
The headlines suggest a constructive near-term setup, with favorable investor screening interest likely supporting sentiment despite limited post-earnings price reaction
Similar Companies in Healthcare
Other companies in the same sector with AI ratings